Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response

Drennan PG., Provine NM., Harris SA., Otter A., Hollett K., Cooper C., De Maeyer RPH., Nassanga B., Ateere A., Pudjohartono MF., Peng Y., Chen J-L., Jones S., Fadzillah NHM., Grifoni A., Sette A., Satti I., Murray SM., Rowe C., Mandal S., Hallis B., Klenerman P., Dong T., Richards D., Fullerton J., McShane H., Coles M.